chrisvoncsefalvay/vaers-outcomes huggingface dataset:
warm to touch; sore arm; red, itchy patch on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy patch on arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (warm to touch), PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy patch on arm). The patient was treated with MOMETASONE for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to touch), PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy patch on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up received on 21-MAY-2021: Reporter contact details added
Woke up on 1/3 with a bad headache, symptoms progressed into a 102.7 fever, severe chills, body aches, fatigue, and diarrhea. Symptoms have subsided except headache as of 1/5
Patient describes wide spread tingling and warm sensation in upper body stretching to the face as well as both arms. She reports no fever but is unable to tell if any erythema as she is African American.  She said it started late last night and has not changed since that time.  She said it felt like she had been out in the sun all day but also the skin was tingling.  Since she described tingling skin and warm sensation I had advised her to be checked for possible allergic reaction.  Pt was going to go to urgent care to get checked out. Pt did report also suffering from anxiety during telephone call and was not sure it it could have contributed to the situation.
An MA reported that a female pt received an injection of Pnu-Imune 23 on 10/17/01. The following day, she developed an injection site reaction characterized by redness, pain and swelling. The pt was treated with Benadryl and unspecified steroids. No further information was available at the date of this report.
She shook, had a fever over 100, feeling sick last night nausea not throwing up. today pt feeling quezzie, sick no fever better today.
Felt terrible; Felt cold; Had a temperature; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt terrible), FEELING COLD (Felt cold), BODY TEMPERATURE (Had a temperature) and VOMITING (Threw up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 014M20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced FEELING ABNORMAL (Felt terrible), FEELING COLD (Felt cold), BODY TEMPERATURE (Had a temperature) and VOMITING (Threw up). At the time of the report, FEELING ABNORMAL (Felt terrible), FEELING COLD (Felt cold), BODY TEMPERATURE (Had a temperature) and VOMITING (Threw up) outcome was unknown.            Treatment information included Tylenol for symptoms
"rash covering the entire body"  wife reported to pharmacy 7/21/21.  Rash does not itch.  Wife called doc. MD advised pt to take zyrtec.   RPh could not reach patient 7/22/22 to see how he has responded
approx. 3 minutes after receiving the vaccine caregiver reported burning sensation on her throat. visible rash noted on her chest. caregiver was observed shaking. taken to the ED, provided care in the ED. D/C same day. Benadryl was given at the ED. Cleared to work that same night.
This spontaneous report as received from a nurse (registered nurse, RN) refers to an unspecified number of unspecified patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unspecified dates, improperly stored doses of VAQTA (strength, dose number, dose, frequency, lot number and indication were not reported) were administered to an unspecified number of unspecified patients. No adverse effects were reported. Concomitant medications were not specified. This is one several reports received from the same reporter (linked to MARRS # 1406USA000549, 1406USA000550, 1406USA000551, 1406USA000552). Additional information has been requested.
Neck pain; Back [and neck] pain; Chills; Fever of 101.7 F; Nausea; Vomiting; This is a non-serious spontaneous case initially received from other health professional on 19-March-2019, concerning a 70-year-old, elderly, female patient.  On 12-Oct-2018, the patient was administered Afluria QIV (influenza vaccine, dose, route of administration, anatomical location, batch number and expiry date: not reported) for an unknown indication and on 11-Mar-2019, at 3:30 pm, the patient was also administered non-company drug glatiramer acetate.  On 11-Mar-2019, 4 months and 27 days after vaccination, at around 08:00 pm, the patient was administered glatiramer acetate and eventually experienced chills, fever of 101.7 F, nausea, vomiting, back pain and neck pain. The symptoms lasted for around 2 hours and then resolved.  The outcome of the events was recovered on 11-Mar-2019.; Reporter's Comments: A 70-year-old female patient experienced neck pain, back pain, chills, fever, nausea and vomiting, four months twenty-seven days after administration of Afluria QIV. The company assessed the causality of the events as not related to the suspect vaccine as there is no plausible temporal relationship between the events and the suspect vaccine.
She woke up immediately went to restroom to vomit. A couple hours later experienced diarrhea felt weak and wanted to go to hospital. A year ago, she had her appendix removed told me she felt like those symptoms. I checked her heart rate it was 145. I took her to the Urgent Care it took about an hour to get there on the way she was fine. When we got there the doctor stated she was in Tachycardia. She was given Ondansetron for nausea and look dehydrated I was advised to get fluids in her.
This spontaneous report as received from a healthcare worker (also reported as Healthcare Prof-other) refers to a patient of unknown age and gender. On 02-MAY-2015 the patient was vaccinated with an improperly stored dose of VATA 25/0.5, injection (lot # K018181, expiry date 04-JUN-2017) (route, dosing regimen and frequency unknown) for an unknown indication. No concomitant medications were reported. No adverse events were reported. There was no product quality complaint reported. The action taken with the therapy with hepatitis a vaccine, inactivated was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with hepatitis a vaccine, inactivated was unknown. This is one of the many reports from the same source. Additional information has been requested.
20 minutes after injection - trouble breathing, numbness and tingling/spasms of hands and face.  Couldn't move mouth.
This spontaneous report was received from a register nurse, refers to a 13 year old patient. The patient's medical history and concurrent conditions were not reported. The register nurse stated that on 25-FEB-2015, the patient was vaccinated with the first dose of PROQUAD (Merck) (inappropriate schedule of drug administration), (strength, dosage, lot# and expiration date were not reported). Concomitant therapy was not reported. No adverse symptoms were reported. Also was informed that the patient was never vaccinated with M-M-R. This is one of two reports received from the same reporter. Additional information has been requested.
Excessive crying for less than 3 hours. Treatment: Tylenol & reassurance.
Developed stiffening joints and then tingling and numbness in feet a few weeks after getting vaccine. Went to Rheumatologist, then endocrinologist, then neurologist, and recently diagnosed with post vaccine Guillain-Barre Syndrome.
Arm hurt a little bit; Tired and fatigued; Low-grade fever; Sneezing; Coughing; Phlegm and muscus, described as post-nasal drip; Sore throat; Blowing the runny nose; Little bit of congestion; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm hurt a little bit), SNEEZING (Sneezing), COUGH (Coughing), UPPER-AIRWAY COUGH SYNDROME (Phlegm and muscus, described as post-nasal drip) and OROPHARYNGEAL PAIN (Sore throat) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for Arthritis, MULTIVITAMIN [VITAMINS NOS], VITAMIN A NOS, COLECALCIFEROL (VITAMIN D3) and CALCIUM for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing), UPPER-AIRWAY COUGH SYNDROME (Phlegm and muscus, described as post-nasal drip), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Blowing the runny nose), NASAL CONGESTION (Little bit of congestion) and PYREXIA (Low-grade fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt a little bit) and FATIGUE (Tired and fatigued). At the time of the report, PAIN IN EXTREMITY (Arm hurt a little bit), SNEEZING (Sneezing), COUGH (Coughing), UPPER-AIRWAY COUGH SYNDROME (Phlegm and muscus, described as post-nasal drip), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Blowing the runny nose), NASAL CONGESTION (Little bit of congestion), FATIGUE (Tired and fatigued) and PYREXIA (Low-grade fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Patient demographic details updated.
Painful and swollen arm commenced 8 hours after injection and subsided after 36 hours. Low-grade fever ranging from 99.6 to 101.2 began 12 hours after injection and lasted 72 hours.
THE MOTHER DESCRIBE THAT REACTION WAS A ITCH IN THE SKIN. THE MOTHER OF THE CHILD USE BENADRYL FOR TREAT THE ITCH. THE ADVERSE EVENT DISAPEAR IN AN HOUR.
Student/pt c/o red, itchy swollen area on back of (R) arm after receiving varicella vaccine.
pain, reddness, hard, hot and itchy at injection site for 2 weeks and 3 days (to date, symptoms are still persisting)
hives within 5-10min after injections; resolved with benadryl headache; did not resolve with tylenol that night I woke up every hour with bad body aches; partially resolved with two aleve the next morning of note; I had very similar symptoms (hives, body aches, fatigue) after my first covid vaccine as well, but not after my 2nd dose or 1st booster dose.
I got the hiccups!  First time was about 11 am on date of 2nd vaccination.  Second time was about 5:15 pm on the date of the vaccination. Third time was about noon/12:15 on the second day.  Each event was short lived and not what I would call "intense"...a casual to moderate hiccupping event.  I have not had the hiccups since.  I normally get the hiccups about two to three times a year.    Otherwise my reaction to the second vaccine was a little fatigue...and feeling a little "off".  nothing to really report...but the hiccups...LOL
L deltoid cellulitis 2d post adminsitration. Tx with Augmentin.
Following the vaccination, I got a swollen left cheek, and heat on my face. And Numbing of my whole left arm. It resolved the next day. -went back to normal. September 7th, my hives returned after 8years of remission. My doctor Believes, the carrier of the hives was triggered by an immune response. Fatigue.
Muscle soreness; This is a spontaneous case, initially received from a pharmacist via pharmaceutical manufacturer (Pfizer) on 14-Feb-2019, concerning a male patient of an unspecified age.  On an unspecified date in 2016, the patient was administered Afluria (TIV) (influenza vaccine, dose: 0.5 ml, frequency reported as 1, route of administration: intramuscular, anatomical location: deltoid, batch number: WT51805, expiry date: 24-May-2017) for an unknown indication.   On an unspecified date, after vaccination, the patient experienced muscle soreness.  The outcome of the event was recovered on an unspecified date.  The reporter considered the case as non-serious.  Case re-opened for completion of full data entry: 14-Feb-2019.  Follow up received from the pharmacist on 19-Apr-2019: The dose (0.5 ml), route of administration (intramuscular) and anatomical location (deltoid) of the suspect vaccine Afluria (TIV) were added in the product tab. The outcome of the event muscle soreness was changed from not reported to recovered in the event tab. The narrative was amended accordingly.  Non-significant follow up received from the pharmacist on 29-Apr-2019: The reporter does not remember the date of birth of the patient and stop date of the event muscle soreness. No new information was received. Hence, no changes were made in the narrative.  Non-significant follow up received from the pharmacist on 06-May-2019: The med info number (SEQ19-01461) was added in the additional information. No information was received regarding patient demographics. Hence, no changes were made in the narrative.; Reporter's Comments: A male patient of an unspecified age experienced muscle soreness on an unspecified date after administration of Afluria (TIV). Due to the lack of information important for the causality assessment, such as onset latency between the vaccination and reported event, the company causality of the event is taken as unassessable.
Patient was administered dose #1 of Moderna on 4/12/21. Upon dose #2, discovered patient DOB at 4/24/04, which places her at 17 years of age. Parent and adolescent counseled by physician regarding age at injection. Parent indicated wish to have daughter complete series. No adverse signs/symptoms on dose #1, nor on dose #2. Reported to medical director at Hospital, which oversees health center. Advised to counsel parent/child and staff involved. Correction plan in place to ensure no repeat of age error.
Tested negative for antibodies one month after the second dose; A spontaneous report was received from a pharmacist concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and tested negative for antibodies one month after the second dose.  The patient's medical history was not provided. No concomitant medications were provided.  The patient received their first of two planned doses of mRNA-1273 (Batch number: 037K20A) on 26 Dec 2020. On 22 Jan 2021, the patient received their second of two planned doses of mRNA-1273 (Batch number: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  The patient received both doses of vaccine and one month after the second dose blood test was performed and tested negative for antibodies (lack of drug effect).  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  The outcome of the event tested negative for antibodies one month after the second dose was not provided.; Reporter's Comments: This refers to a case of a female patient who received both mRNA-1273 doses within a month (lot #s 037K20A, 043L20A) and experienced drug ineffective with no associated AEs.
Urticarial started 7.5 hours after vaccine. Seen 24 plus hours after vaccination. No respiratory symptoms, nausea, vomiting, angioedema.
I tested positive for Covid 19; I tested positive for Covid 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single, administration date May2021 (Batch/Lot number: unknown) as dose 2, single and administration date May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 05Jan2022, outcome "unknown" and all described as "I tested positive for Covid 19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (05Jan2022) positive. Clinical course: Patient took the 2 doses of the Pfizer vaccine in May2021 and followed it up with a booster in Nov2021. The booster made patient sick. Around 05Jan2022, patient tested positive for Covid 19, although Covid symptoms started on 31Dec2021. Patient's unvaccinated family who had been around the patient several days never contracted Covid. Patient thought there were two issues here: 1) The vaccine had not protected patient against Covid despite claims of Pfizer, the news media and government officials. 2) Patient's family did not contract Covid while patient was positive and exposed to them. One can conclude that the Covid vaccine either gave patient Covid or weakened patient's immune system as to make patient more susceptible to Covid. Patient thought a refund of the cost of the vaccine along with missing work, doctors visits, pain and suffering should be the least Pfizer provides. Inevitably, the larger population of this world was going to band together and bring a class action suit against Pfizer for false claims, and misrepresentation.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Per the mother, patient started vomiting and broke out in a rash on his face when they were pulling out of the doctor's office parking lot. Mom states that the patient is also very sleepy. Patient is scratching rash in the office, and the rash has spread to back and legs. He was pale when he came back to the office. Patient was examined by doctor. No difficuly breathing noted. He was given 1 tsp po of BENADRYL. He was watched for 45 minutes. Patient was alert, color was good, no difficulty when he left the office.
Patient (nursing home employee) was given his second dose of the Covid 19 vaccine today (March 24,2021) during a routine nursing home vaccination clinic.  Patient was given his second dose at 8:35 am and at 8:39 am he was complaining of shortness of breath, chest pain, as we as pain in his extremities.  Patient stooped in chair and lowered to the ground. Epi Pen 0.3 mg was administered by the attending pharmacist, at 8:41 am and the ambulance was called.  HIs vital signs were taken: Blood pressure 123/77, Oxygen 99%, pulse ranged from 104 to 111 bpm.  Patient complained of pins/needles feeling in extremities, his arms (both left and right) were contracting, and his pupils were dilated.  He was given 4 L oxygen, and the ambulance arrived at 8:58 am.
SHORTNESS OF BREATH WHILE WALKING; FEELING LIKE HE WAS GOING TO DIE; HIGH BLOOD PRESSURE; SEVERE CHEST PAIN/ON AND OFF CHEST PAIN; SEVERE BACK PAIN; DIFFICULTY SLEEPING; TIREDNESS; NUMBNESS IN LEFT ARM; WEAKNESS; CRAZY JOINT PAIN IN LEFT ARM; This spontaneous report received from a patient concerned a 41 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, no alcohol use, and smoker (smokes cigarettes twice a day), and other pre-existing medical conditions included patient had no known allergies. patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 19-MAR-2021, the subject experienced crazy joint pain in left arm. On 21-MAR-2021, the subject experienced weakness. On 23-MAR-2021, the subject experienced numbness in left arm. On 28-MAR-2021, the subject experienced tiredness. On APR-2021, Laboratory data included: Blood pressure (NR: not provided) up, Blood test (NR: not provided) negative, CBC (NR: not provided) negative, ECG (NR: not provided) unknown, Imaging procedure (NR: not provided) negative, Troponin (NR: not provided) negative, and X-ray NOS (NR: not provided) unknown. On 04-APR-2021, the subject experienced shortness of breath while walking. On 04-APR-2021, the subject experienced feeling like he was going to die. On 04-APR-2021, the subject experienced high blood pressure. On 04-APR-2021, the subject experienced severe chest pain/on and off chest pain. On 04-APR-2021, the subject experienced severe back pain. On 04-APR-2021, the subject experienced difficulty sleeping. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from numbness in left arm on 26-MAR-2021, and difficulty sleeping on 06-APR-2021, was recovering from shortness of breath while walking, and severe back pain, had not recovered from weakness, tiredness, severe chest pain/on and off chest pain, and crazy joint pain in left arm, and the outcome of high blood pressure and feeling like he was going to die was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.
Pt received her 1st injection of the series at the age of 16 versus the required age of 18 y/o.  Nurse called and spoke with mom to notify of the finding and to check in on pt.  Mom reported that pt denied and s/s post vaccination and reported that she spoke with child's PCP who agreed with CDC recommendation to finish series.
04/03/2003 9:00am malaise with chills. Also felt shaky. 04/03/03 7:00 pm Hands and feet contractions with tingling in both. Cont. to feel shaky. Went to ER but did not wait for exam by MD. 04/04/03 Continues to feel shaky. Advised to see PCP
Hotness; Aches; Chills; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hotness), MYALGIA (Aches), CHILLS (Chills) and VOMITING (Vomiting) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced FEELING HOT (Hotness), MYALGIA (Aches), CHILLS (Chills) and VOMITING (Vomiting). On 16-Mar-2021, VOMITING (Vomiting) had resolved. At the time of the report, FEELING HOT (Hotness), MYALGIA (Aches) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Information has been received from a nurse practitioner concerning a female patient who was vaccinated with a 0.5ml dose of Gardasil. Subsequently, the patient experienced severe pain in her arm after the vaccination. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
broke out in chickenpox 8 days p/vax;no hx of exposure;
The patient experienced a large local reaction of the left arm with a 5cm x 7cm red, swelling area.